A practical and robust mechanistic biomarker of pseudo-progression on immune checkpoint inhibitor therapy.

Project: Research

Project Details

StatusActive
Effective start/end date1/02/202431/01/2026

Collaborative partners

Funding

  • Melanoma Focus: £20,000.00